Xie HG - Search Results

1

Genetic analysis of the S-mephenytoin polymorphism in a Chinese population.

de Morais SM, Goldstein JA, Xie HG, Huang SL, Lu YQ, Xia H, Xiao ZS, Ile N, Zhou HH. de Morais SM, et al. Among authors: xie hg. Clin Pharmacol Ther. 1995 Oct;58(4):404-11. doi: 10.1016/0009-9236(95)90053-5. Clin Pharmacol Ther. 1995. PMID: 7586932

2

Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.

Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH. Xiao ZS, et al. Among authors: xie hg. J Pharmacol Exp Ther. 1997 Apr;281(1):604-9. J Pharmacol Exp Ther. 1997. PMID: 9103550

3

Evidence for the effect of gender on activity of (S)-mephenytoin 4'-hydroxylase (CYP2C19) in a Chinese population.

Xie HG, Huang SL, Xu ZH, Xiao ZS, He N, Zhou HH. Xie HG, et al. Pharmacogenetics. 1997 Apr;7(2):115-9. doi: 10.1097/00008571-199704000-00004. Pharmacogenetics. 1997. PMID: 9170148

4

Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects.

Qin XP, Xie HG, Wang W, He N, Huang SL, Xu ZH, Ou-Yang DS, Wang YJ, Zhou HH. Qin XP, et al. Among authors: xie hg. Clin Pharmacol Ther. 1999 Dec;66(6):642-6. doi: 10.1016/S0009-9236(99)90075-9. Clin Pharmacol Ther. 1999. PMID: 10613621

5

High-performance liquid chromatographic determination of urinary 4'-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans.

Xie HG, Huang SL, Zhou HH. Xie HG, et al. J Chromatogr B Biomed Appl. 1995 Jun 9;668(1):125-31. doi: 10.1016/0378-4347(95)00065-q. J Chromatogr B Biomed Appl. 1995. PMID: 7550968

6

Genetic polymorphisms of debrisoquine and S-mephenytoin oxidation metabolism in Chinese populations: a meta-analysis.

Xie HG, Xu ZH, Luo X, Huang SL, Zeng FD, Zhou HH. Xie HG, et al. Pharmacogenetics. 1996 Jun;6(3):235-8. doi: 10.1097/00008571-199606000-00005. Pharmacogenetics. 1996. PMID: 8807662

7

In vivo inhibition of CYP2C19 but not CYP2D6 by fluvoxamine.

Xu ZH, Xie HG, Zhou HH. Xu ZH, et al. Among authors: xie hg. Br J Clin Pharmacol. 1996 Oct;42(4):518-21. doi: 10.1046/j.1365-2125.1996.45319.x. Br J Clin Pharmacol. 1996. PMID: 8904628 Free PMC article.

8

Effect of troleandomycin on the pharmacokinetics of imipramine in Chinese: the role of CYP3A.

Wang JS, Wang W, Xie HG, Huang SL, Zhou HH. Wang JS, et al. Among authors: xie hg. Br J Clin Pharmacol. 1997 Aug;44(2):195-8. doi: 10.1046/j.1365-2125.1997.00649.x. Br J Clin Pharmacol. 1997. PMID: 9278210 Free PMC article. Clinical Trial.

9

No correlation between side-chain of propranolol oxidation and S-mephenytoin 4'-hydroxylase activity.

Xie HG, Xu ZH, Huang SL, Liu JH, Wu JX, Jiang CH, Zhou HH. Xie HG, et al. Zhongguo Yao Li Xue Bao. 1997 May;18(3):216-8. Zhongguo Yao Li Xue Bao. 1997. PMID: 10072936 Free article.

10

Determination of S/R ratio of mephenytoin in human urine by chiral HPLC and ultraviolet detection and its comparison with gas chromatography.

Huang SL, Xie HG, Wang W, Xu ZH, Jiang CH, Zhou HH. Huang SL, et al. Among authors: xie hg. Zhongguo Yao Li Xue Bao. 1998 Nov;19(6):548-50. Zhongguo Yao Li Xue Bao. 1998. PMID: 10437143 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters